Doctors test for blood clots using a combination of risk scoring, blood tests, and imaging, with the specific approach depending on where they suspect the clot is located. The process typically starts with a clinical assessment, moves to a blood test called D-dimer, and then to imaging like ultrasound or CT scan if needed. Most people get an answer within hours of arriving at a hospital or clinic.
The First Step: Clinical Risk Scoring
Before ordering any tests, your doctor will assess how likely it is that you actually have a clot. They use a standardized scoring system called the Wells Score, which assigns points based on your symptoms and medical history. Visible leg swelling with pain earns 3 points. A heart rate above 100 beats per minute adds 1.5 points. Recent immobilization or surgery within the past four weeks adds another 1.5. A history of previous blood clots contributes 1.5 points, and active cancer adds 1 point.
A total score of 4 or below puts you in the low-probability category. Scores between 4.5 and 6 suggest moderate risk, and anything above 6 indicates a high likelihood of a clot, particularly a pulmonary embolism (a clot in the lungs). This score determines what happens next. Low-risk patients typically get a blood test first, while high-risk patients may skip straight to imaging.
D-Dimer: The Blood Test That Rules Clots Out
The D-dimer test measures tiny protein fragments that your body releases when it breaks down a blood clot. If your D-dimer level is normal, it’s extremely unlikely you have a clot. The test has a sensitivity around 97%, meaning it catches nearly every case. When combined with age-adjusted cutoffs (which account for the fact that D-dimer naturally rises as you get older), sensitivity reaches 99%.
The catch is that D-dimer is much better at ruling clots out than confirming them. Its specificity is only about 41%, which means more than half of positive results aren’t caused by an actual clot. Pregnancy, recent surgery, trauma, infections, heart disease, and rheumatoid arthritis can all push D-dimer levels up without any clot being present. Elderly patients are particularly prone to elevated readings. So a normal D-dimer is reassuring and often ends the workup entirely, but an elevated result simply means you need imaging to find out what’s going on.
Ultrasound for Leg Clots
If your doctor suspects a deep vein thrombosis, or DVT, in your leg, the go-to test is a complete duplex ultrasound. This is noninvasive, painless, and doesn’t involve any radiation. A technician presses a handheld probe along your leg from the groin to the ankle, systematically compressing the deep veins at each level. A healthy vein collapses flat under gentle pressure. A vein containing a clot won’t compress fully, and that’s the primary sign doctors look for.
The “duplex” part means the test combines two technologies. Standard ultrasound creates a picture of the vein’s structure, while Doppler ultrasound tracks blood flow in real time using color and sound. Color Doppler can show whether a vein is partially or completely blocked, and it’s especially helpful for visualizing smaller veins that are harder to compress manually. Spectral Doppler adds another layer: it records the rhythm of blood flow. In a normal vein, flow rises and falls with your breathing. A flat, continuous waveform suggests something is blocking flow further upstream, possibly a clot in the pelvis or abdomen that wouldn’t be visible on a standard leg scan.
The whole exam typically takes 30 to 45 minutes. Results are usually available the same day.
CT Scan for Lung Clots
When a pulmonary embolism is suspected, the standard test is a CT pulmonary angiogram, or CTPA. This is a specialized CT scan where iodine-based contrast dye is injected into a vein in your arm at a high flow rate (about 4 milliliters per second) to make the blood vessels in your lungs light up on the scan. Any clot shows up as a dark gap within the bright, contrast-filled artery.
CTPA has become the default test at most hospitals because it’s fast, widely available, and highly accurate. The landmark PIOPED II study found it has a specificity of 96%, meaning false positives are rare. Sensitivity sits around 83% for CTPA alone, but when combined with CT imaging of the leg veins in the same session, sensitivity climbs to 90% with 95% specificity. More recent multi-detector scanners can detect clots all the way down to the smallest branches of the pulmonary arteries, with some studies reporting sensitivity between 90% and 100%.
The scan itself takes only a few seconds of breath-holding. You’ll feel a warm flush when the contrast enters your bloodstream, and some people notice a metallic taste. The main limitations are for people with severe kidney problems or contrast allergies, since the iodine dye can be hard on the kidneys.
MRI for Hard-to-Reach Clots
Ultrasound works well for leg veins, but it has blind spots. Clots in the pelvic veins, the abdomen, or the veins inside the skull are difficult or impossible to see with a standard ultrasound probe. In these cases, doctors may order magnetic resonance venography (MRV), an MRI technique specifically designed to image veins.
Contrast-enhanced MRV, where a gadolinium-based dye is injected to highlight blood vessels, provides high-resolution images of the pelvic venous system. This matters because deep pelvic veins can harbor clots that act as a source for pulmonary emboli or even strokes in people with a small heart defect called a patent foramen ovale. Older non-contrast MRV techniques relied on the natural flow of blood to generate images, which made them less reliable in veins where blood moves slowly or in unusual directions. Modern contrast-enhanced versions are more dependable, with about 96% of patients in recent studies receiving this improved approach.
MRV is not a first-line test. It’s typically reserved for situations where ultrasound results are inconclusive, where pelvic or abdominal clots are specifically suspected, or where CT contrast dye can’t be used safely.
Testing for Why the Clot Formed
Once a clot is confirmed, doctors sometimes investigate whether an underlying clotting disorder made you prone to it. This is especially common if you’re young, have no obvious risk factors, or have had more than one clot. The workup is called thrombophilia testing, and it involves a panel of blood tests looking for both inherited and acquired conditions.
The most commonly tested genetic conditions are Factor V Leiden and prothrombin G20210A, both mutations that make blood clot more easily than it should. Doctors also check levels of three natural anticlotting proteins: antithrombin, protein C, and protein S. Deficiencies in any of these tilt the balance toward clot formation. On the acquired side, the panel typically includes tests for antiphospholipid syndrome, an autoimmune condition detected through lupus anticoagulant, anticardiolipin antibodies, and anti-beta-2 glycoprotein antibodies.
Timing matters for these tests. Some results are unreliable if drawn while you’re on blood thinners or in the acute phase of a clot, so your doctor may delay certain parts of the panel for weeks or months. Not everyone with a blood clot needs thrombophilia testing. It’s most useful when the results would change how long you stay on blood thinners or help family members understand their own risk.
How the Tests Work Together
The diagnostic process is designed as a funnel. The Wells Score filters out people at very low risk. The D-dimer test eliminates the large group whose symptoms have a different cause. Imaging confirms or rules out a clot in the remainder. This layered approach means most people don’t need a CT scan or extensive blood work, and those who do get fast, targeted answers.
For a suspected leg clot, the typical path is risk scoring, then D-dimer, then ultrasound if the D-dimer is elevated. For a suspected lung clot, it’s risk scoring, then D-dimer (in low-to-moderate risk patients), then CTPA if needed. High-risk patients often go directly to imaging because a negative D-dimer wouldn’t be trusted enough to rule out a potentially life-threatening pulmonary embolism. In most emergency departments, the entire workup from initial assessment to diagnosis takes a few hours.